Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:10/5/2009

a B cell, as well as killer T cells that travel to the infection to kill the influenza infected cells. Although the T cells and antibody are very important to control and eliminate the virus infection, it takes a long time (up to about 8 days) before they are ready to do so. By this time, the virus has spread extensively and caused considerable damage. Even though these immune protections are important for controlling the spread of the virus, they are also very destructive. Like an ever expanding forest-fire or a growing war zone, the longer the virus has to reproduce and spread, the harder it is to control, the more damage it causes and the more damage the immune response causes to control the infection, peripheral damage to the lung and surrounding tissue.

The virus damaged tissue in the respiratory tract is now also more susceptible to the bacteria that normally reside in the nose, including Staphylococcus aureus. The virus kills the ciliated epithelium that pushes these bacteria out of the lungs and dissolves the mucous lining that protects the underlying cells. The infection also exposes cells that are more susceptible to the bacteria. As a result, many people who are infected with influenza end up with a bacterial pneumonia that can be life threatening.

The new H1N1 swine flu virus is a much more lethal virus than previous influenza viruses, including previous H1N1 influenzas. Unlike other influenzas, the new H1N1 virus is especially lethal in young adults. It appears that H1N1 may be able to bind to more cells in the lung, reproduce faster, and spread faster. The more cells that are infected, the more difficult it is for the immune system to eliminate the virus and the more damage the immune system causes by inflammation during the process. Also, H1N1 may cause even more cytokines to be produced which also make the inflammation much more severe. This is called a cytokine storm. Young adults, as they have a v
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
2. CEL-SCI Expands H1N1 Flu Virus Work
3. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
4. CEL-SCI Posts New Corporate Presentation to Website
5. CEL-SCI Corporation Releases Letter to Shareholders
6. CEL-SCI Corporation Releases Letter to Shareholders
7. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
8. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
9. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Corporation Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Calif., April 30, 2015 Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... GAAP results: Revenue for the first quarter of 2015 ... the first quarter of 2014, and down $5.3 million ... First quarter 2015 net income as reported in ...
(Date:4/30/2015)... VIEW, Calif. , April 30, 2015  IRIDEX ... will release its first quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
(Date:4/30/2015)... -- Thoratec Corporation (NASDAQ: THOR ), a world leader ... restore failing hearts, said today it will participate in ... on Thursday, May 14. D. Keith ... an update on the company, beginning at 10:40 a.m., ... The presentation will be available through the conference ...
Breaking Medicine Technology:Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2
... Nov. 9 New data from the JUPITER,study ... major cardiovascular (CV) events (defined in this,study as ... hospitalization for unstable angina, or death from CV,causes) ... among men and women,with elevated hsCRP but low ...
... 7 Data from an investigational,open-label, randomized ... alfa) in treating anemia in subjects with ... were presented today at the American Society,of ... dosing groups, including the FDA-approved,three-times-per-week (TIW) regimen, ...
Cached Medicine Technology:CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 2CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 3CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 4CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company ... at the , May 5 - 7, 2015 Minnesota ... at the conference include its bestselling TaskMate sit stand ... the 6100 TaskMate Executive. Features of the 6100 TaskMate ... tray, extended platform work surface and supply holders. Weighing ...
(Date:5/2/2015)... 2015 “ ActOn ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... with organizations to make a difference. , In this material ... things that aren’t about money, which is why those things ...
(Date:5/2/2015)... May 02, 2015 “ Peachtree Audio ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... audio equipment. , Music is an important part ... be pampered and given the royal treatment. Peachtree Audio ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 ZoomCare, the ... has submitted plans to offer its new healthcare insurance ... The ZOOM+ Personal Health Insurance System is the nation’s ... to enhance human performance. ZOOM+ Personal Health Insurance was ... delivery system that are subject to review and regulation ...
(Date:5/1/2015)... Farmington NY (PRWEB) May 01, 2015 ... world, will share the latest in their reclaimed wood ... (ICFF) at the Jacob Javits Center in NYC this ... Prairie Boards, will bring much anticipated texture and color ... “We've seen an explosion of texture and color in ...
Breaking Medicine News(10 mins):Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3
... ... Makrolon® LD polycarbonate sheet for LED back lit sign faces at the 2010 International ... its presentation, “History and Evolution of Plastic Sign Faces,” as the latest technological step ... ...
... became ill with 2009 H1N1 influenza developed drug-resistant strains ... report doctors from the National Institute of Allergy and ... Health. Doctors who treat prolonged influenza infection should be ... may lead to drug-resistant virus, say the authors, and ...
... and survival rates don,t improve, study finds , FRIDAY, March ... breast has been treated for breast cancer does not ... be free of disease or live longer, new research has ... genes known as BRCA1 and BRCA2 -- have a much ...
... Act for ... ... puzzling at first, but there,s a crafty and creative way families can help people living with ... Seals to launch an in-store campaign and crafting event that asks customers to Act ...
... advanced tumors noted in study , FRIDAY, March 26 (HealthDay ... face a higher risk of developing the most aggressive types ... cause-and-effect relationship, a new study finds. , Researchers also don,t ... cancer than others. Overall, breast-feeding is thought to reduce the ...
... ... denture repair, Stirling Dental Laboratory, donates to local and national organizations to help individuals ... ... broken denture repair and services, continues its efforts in giving back to the ...
Cached Medicine News:Health News:New Polycarbonate Sign Face Material Eliminates Hot Spots, Optimizes Light Uniformity in LED Back-Lit Signs 2Health News:New Polycarbonate Sign Face Material Eliminates Hot Spots, Optimizes Light Uniformity in LED Back-Lit Signs 3Health News:Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases 2Health News:Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases 3Health News:Preventive Mastectomy May Not Lower Risks 2Health News:A.C. Moore Arts & Crafts, Inc. Offers Creative Way to Help Easter Seals and Families Living with Autism 2Health News:A.C. Moore Arts & Crafts, Inc. Offers Creative Way to Help Easter Seals and Families Living with Autism 3Health News:Long-Term Breast-Feeding Tied to More Aggressive Cancers 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 3
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... in our largest chest freezer, with 20.7 ... 52,700 samples -- (572) 2" boxes. Like ... utilizes ultra-thin vacuum insulation panel technology to ... Patented Tollesbury Technology improves sample preservation, reduces ...
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... Premium Model U570 is an ... standards as Innova models. Comparable in ... model uses conventional cascade refrigeration and ... price point. Holds 400 2" boxes. ...
Medicine Products: